Related Experiment Video
Updated: Apr 23, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Peritonitis in a continuous ambulatory peritoneal dialysis patient by two different species of enterococci: A rare
H P Nepal1, B Khanal2, S K Sharma3
1Department of Microbiology, Chitwan Medical College Teaching Hospital, Chitwan, Nepal.
Abstract:
Peritonitis in a continuous ambulatory peritoneal dialysis patient by two different species of enterococci is a rare condition. We report a case of peritonitis from which vancomycin sensitive Enterococcus faecalis and vancomycin resistant Enterococcusc faecium were isolated. It also emphasizes the effectiveness of linezolid for the treatment of vancomycin resistant enterococcal infection.
Insights
A rare case of peritonitis in a continuous ambulatory peritoneal dialysis patient involved two enterococci species. Vancomycin-resistant Enterococcus faecium was effectively treated with linezolid.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment for end-stage renal disease.
- Peritonitis is a serious complication of CAPD, often caused by bacterial infections.
- Enterococcal species are a known cause of CAPD-related peritonitis.
Observation:
- This report details a rare instance of CAPD peritonitis caused by two distinct enterococcal species.
- The isolated pathogens were vancomycin-sensitive Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.
- The patient presented with symptoms indicative of peritonitis.
Findings:
- The study successfully identified dual enterococcal species contributing to peritonitis in a CAPD patient.
- Vancomycin resistance was confirmed in the Enterococcus faecium isolate.
- The case highlights the challenge of treating infections with multidrug-resistant organisms in immunocompromised patients.
Implications:
- This case underscores the importance of accurate pathogen identification and susceptibility testing in CAPD peritonitis.
- It demonstrates the clinical utility of linezolid as a treatment option for vancomycin-resistant enterococcal infections.
- Findings may inform treatment guidelines for complex CAPD-related infections, particularly those involving resistant bacteria.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Endocarditis IV: Nursing Management
Continuous Renal Replacement Therapy

